Literature DB >> 11129679

Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction.

P Bettencourt1, A Ferreira, N Pardal-Oliveira, M Pereira, C Queirós, V Araújo, M Cerqueira-Gomes, M J Maciel.   

Abstract

BACKGROUND: Risk stratification after acute myocardial infarction (AMI) includes the evaluation of left ventricular (LV) function. Natriuretic peptides, and particularly brain natriuretic peptide (BNP), emerged as a potential marker of ventricular function and prognosis after AMI. HYPOTHESIS: Brain natriuretic peptide levels are related to ventricular function, either systolic or isolated diastolic, and can give prognostic information in patients surviving AMI.
METHODS: In all, 101 patients were enrolled. An echocardiographic (M-mode, two-dimensional, and pulsed Doppler) evaluation was performed and blood samples for BNP measurement were obtained. Clinical events were recorded during 12 months of follow-up.
RESULTS: A negative correlation between BNP and LV ejection fraction was observed (r = -0.38; p < 0.001). The BNP levels were higher among patients with LV systolic dysfunction than in patients with isolated diastolic dysfunction (339.1 +/- 249.9 vs. 168.0 +/- 110.5 pg/ml, p = 0.001). The latter had higher levels of BNP than those with normal LV function (68.3 +/- 72.6 pg/ml, p < 0.001). The BNP accuracy to detect LV systolic dysfunction was good (area under the ROC curve [AUC] = 0.83) and increased when isolated diastolic dysfunction was also considered (AUC = 0.87). Brain natriuretic peptide had a very good accuracy in the prediction of death (AUC = 0.95) and the development of heart failure (AUC = 0.90).
CONCLUSION: These results extend previous evidence relating BNP to systolic function after AMI. Furthermore, a relationship between BNP levels and diastolic function was found. Brain natriuretic peptide had a very good performance in detecting the occurrence of an adverse event. We conclude that BNP can detect high-risk patients and help select patients for more aggressive approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129679      PMCID: PMC6654948          DOI: 10.1002/clc.4960231213

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  24 in total

1.  Brain natriuretic peptide as a marker of cardiac involvement in hypertension.

Authors:  P Bettencourt; A Ferreira; T Sousa; L Ribeiro; F Brandão; J Polónia; M Cerqueira-Gomes; L Martins
Journal:  Int J Cardiol       Date:  1999-05-15       Impact factor: 4.164

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

3.  Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction.

Authors:  C C Lang; N Prasad; H M McAlpine; C Macleod; B J Lipworth; T M MacDonald; A D Struthers
Journal:  Am Heart J       Date:  1994-06       Impact factor: 4.749

4.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G S Francis; C Benedict; D E Johnstone; P C Kirlin; J Nicklas; C S Liang; S H Kubo; E Rudin-Toretsky; S Yusuf
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

5.  N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

Authors:  C Hall; J L Rouleau; L Moyè; J de Champlain; D Bichet; M Klein; B Sussex; M Packer; J Rouleau; M O Arnold
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

6.  Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction.

Authors:  T Omland; V V Bonarjee; R T Lie; K Caidahl
Journal:  Am J Cardiol       Date:  1995-08-01       Impact factor: 2.778

7.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

Authors:  J G Motwani; H McAlpine; N Kennedy; A D Struthers
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

9.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

10.  Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.

Authors:  V V Bonarjee; T Omland; D W Nilsen; K Caidahl; J A Sundsfjord; K Dickstein
Journal:  Br Heart J       Date:  1995-06
View more
  4 in total

Review 1.  Diagnosis of heart failure in primary care.

Authors:  Cândida Fonseca
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

2.  Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial Infarction.

Authors:  A Fazlinezhad; M Khadem Rezaeian; H Yousefzadeh; K Ghaffarzadegan; M Khajedaluee
Journal:  Clin Med Insights Cardiol       Date:  2011-08-30

3.  Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis.

Authors:  James B Wetmore; Rajyalakshmi Gadi; John H Lee; James H O'Keefe; Paul S Chan; Fengming Tang; John A Spertus
Journal:  BMC Res Notes       Date:  2011-12-15

4.  Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction.

Authors:  Laura Ajello; Giuseppe Coppola; Egle Corrado; Eluisa La Franca; Antonino Rotolo; Pasquale Assennato
Journal:  ISRN Cardiol       Date:  2013-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.